(MedPage Today) — FDA staff members had no major concerns or questions about the safety, accuracy, risks, or benefits of the Galleri multicancer early detection (MCED) blood test ahead of an advisors’ meeting that will be held Wednesday.
The…
Source link
FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test
